Lv3
334 积分 2025-04-17 加入
Preserving the CTLA-4 Checkpoint for Safer and More Effective Cancer Immunotherapy
1天前
已完结
Hijacking antibody-induced CTLA-4 lysosomal degradation for safer and more effective cancer immunotherapy
1天前
已完结
How Does an Anti-CTLA-4 Antibody Promote Cancer Immunity?
1天前
已完结
An innovative antibody fusion protein targeting PD-L1, VEGF and TGF-β with enhanced antitumor efficacies
2天前
已完结
IRG1/itaconate rewires macrophage and lung tumor metabolism through G6PD inhibition
3天前
已完结
Bridging EGFR/TGF-β Signaling to Bypass Resistance to Immune Checkpoint Blockade
4天前
已完结
An Antibody–Drug Conjugate Directed to Tissue Factor Shows Preclinical Antitumor Activity in Head and Neck Cancer as a Single Agent and in Combination with Chemoradiotherapy
4天前
已完结
Fab-based bispecific antibody formats with robust biophysical properties and biological activity
9天前
已完结
Membrane-Proximal Epitope Facilitates Efficient T Cell Synapse Formation by Anti-FcRH5/CD3 and Is a Requirement for Myeloma Cell Killing
9天前
已完结
Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodies
9天前
已完结
皖公网安备34019202002308
